Daniel J McGrail

27PUBLICATIONS
263CO-AUTHORS
Neural networksApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 29, 2026
eSIG-Net: an interaction language model that decodes the protein code of single mutations.

|Apr 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study.

|Apr 13, 2026
Axitinib plus Avelumab in Recurrent/Metastatic Adenoid Cystic Carcinoma: Biomarker Analysis and Updated Results of the Phase II Trial.

Camilla O Hoff, Simon Heeke, Yoshitsugu Mitani

|Jan 07, 2026
Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer.

Sarah K Herzog, Jessica H Stevens, Guowei Gu

|Jan 02, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer.

Nadeem Riaz, Tyler J Alban, Robert I Haddad

|Jan 02, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma.

Natalie L Silver, Jin Dai, Travis D Kerr

Pageof 5

Frequent Collaborators

7 joint publications

Nidhi Sahni

5 joint publications

Shiaw-Yih Lin

5 joint publications

S Stephen Yi

3 joint publications

Renata Ferrarotto